Physician Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Physician Wealth Advisors's PFE Position: Q1 2026 in Review
Physician Wealth Advisors increased its Pfizer (PFE) stake by 10% in Q1 2026, buying an estimated $26.5K and bringing the position to 10,522 shares worth $295K. The position accounts for 0.04% of the portfolio, ranked #150.
Physician Wealth Advisors first reported a position in PFE in Q3 2019 and has held it in 27 quarters since. The position peaked at $651K in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Physician Wealth Advisors held 10,522 shares of Pfizer worth $295K as of Q1 2026.
- Physician Wealth Advisors bought 997 Pfizer shares in Q1 2026, an estimated $26.5K.
- Pfizer made up 0.04% of Physician Wealth Advisors's portfolio in Q1 2026, its #150 holding.
- Physician Wealth Advisors first reported a position in Pfizer in Q3 2019 and has held it in 27 quarters since.
- Physician Wealth Advisors's Pfizer position peaked at $651K in Q4 2021.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Physician Wealth Advisors's 13F filing for Q1 2026, filed 24 Apr 2026.